Oh Young Bang/LinkedIn
Nov 9, 2025, 12:28
Oh Young Bang on Enhancement of Post-Stroke Neuroregeneration
Oh Young Bang, Professor of Neurology at Samsung Medical Center, CEO at S and E bio, shared on LinkedIn:
”We’re confirming safety in stroke patients first, then moving on to drug-loaded exosome treatments for neurodegeneration (PMID: 40883738).
The BBB-bypass approach would be key.”
Read the full article here.
Article: Engineered MSC-EVs loaded with BDNF-enhancing neuropeptides via a non-disruptive method enhance post-stroke neuroregeneration via intranasal delivery
Authors: Ji-Eun Kim, Ye Eun Ji, Hyeon Jun Hwang, Ga-Eun Go, Hyung-Jun Lim, Jaein Yoo, Jooho Kim, Doil Park, Eun Hee Kim, Doory Kim, Oh Young Bang
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 8, 2026, 17:50From Bleeding to Swelling – A Shared Therapeutic Revolution in Rare Diseases – RPTH Journal
-
Jun 8, 2026, 17:36Sophia Delicou: Decoding Acute Pain Transfusion Reactions in Thalassemia
-
Jun 8, 2026, 16:21Ifeanyichukwu Ifechidere: Reflections on the UK NEQAS Coagulation and Haemostasis Conference
-
Jun 8, 2026, 16:00Despina Fotiou: Advancing Recognition Through Global Case Collaboration
-
Jun 8, 2026, 15:43Jigyasa Pal: Beyond Care – Empowering Lives with HPAP
-
Jun 8, 2026, 15:36New Approaches in Bleeding Disorders Care – SAHF
-
Jun 8, 2026, 15:34Besher Shami: A Unique Presentation of Warfarin-Associated Aortic Perforation
-
Jun 8, 2026, 15:29Shreyashree Sarkar: Oxidative Stress and Neutrophil-Driven Mechanisms in Cancer-Associated Thrombosis at Vascular Discovery 2026
-
Jun 8, 2026, 15:23Gloria Duah: Can a Blood Transfusion Change Your Blood Type?